{"quote": {"result": [{"language": "en-US", "region": "US", "quoteType": "EQUITY", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "marketState": "PRE", "regularMarketPrice": 8.84, "exchangeTimezoneShortName": "EDT", "exchangeTimezoneName": "America/New_York", "currency": "USD", "market": "us_market", "esgPopulated": false, "messageBoardId": "finmb_615639771", "gmtOffSetMilliseconds": -14400000, "shortName": "Icosavax, Inc.", "longName": "Icosavax, Inc.", "regularMarketChangePercent": 10.224435, "exchange": "NMS", "regularMarketChange": 0.8199997, "regularMarketTime": 1684180804, "regularMarketDayHigh": 9.29, "regularMarketDayRange": "7.88 - 9.29", "regularMarketDayLow": 7.88, "regularMarketVolume": 176907, "regularMarketPreviousClose": 8.02, "bid": 0.0, "ask": 0.0, "bidSize": 18, "askSize": 11, "fullExchangeName": "NasdaqGS", "financialCurrency": "USD", "regularMarketOpen": 7.98, "averageDailyVolume3Month": 143170, "averageDailyVolume10Day": 125490, "fiftyTwoWeekLowChange": 6.5600004, "ipoExpectedDate": "2021-07-29", "averageAnalystRating": "1.4 - Strong Buy", "tradeable": false, "cryptoTradeable": false, "fiftyTwoWeekLowChangePercent": 2.8771932, "fiftyTwoWeekRange": "2.28 - 16.45", "fiftyTwoWeekHighChange": -7.6100006, "fiftyTwoWeekHighChangePercent": -0.462614, "fiftyTwoWeekLow": 2.28, "fiftyTwoWeekHigh": 16.45, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "epsTrailingTwelveMonths": -2.42, "epsForward": -2.12, "epsCurrentYear": -2.53, "priceEpsCurrentYear": -3.4940712, "sharesOutstanding": 41418100, "bookValue": 5.298, "fiftyDayAverage": 6.4558, "fiftyDayAverageChange": 2.3842, "fiftyDayAverageChangePercent": 0.36931133, "twoHundredDayAverage": 6.234975, "twoHundredDayAverageChange": 2.6050253, "twoHundredDayAverageChangePercent": 0.41780847, "marketCap": 366136000, "forwardPE": -4.1698117, "priceToBook": 1.6685542, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "firstTradeDateMilliseconds": 1627565400000, "priceHint": 2, "displayName": "Icosavax", "symbol": "ICVX"}], "error": null}, "summary": {"result": [{"assetProfile": {"address1": "1930 Boren Avenue", "address2": "Suite 1000", "city": "Seattle", "state": "WA", "zip": "98101", "country": "United States", "phone": "206 737 0085", "website": "https://icosavax.com", "industry": "Biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "longBusinessSummary": "Icosavax, Inc., a biopharmaceutical company, develops vaccines against infectious diseases through virus-like particle (VLP) platform technology. Its lead product candidate IVX-A12, a respiratory syncytial virus (RSV) and human metapneumovirus (hMPV) VLP vaccine. The company also develops IVX-121, a vaccine candidate with RSV target and is under Phase 1/1b clinical trial; and IVX-241, a vaccine candidate with hMPV target. Icosavax, Inc. was incorporated in 2017 and is headquartered in Seattle, Washington.", "fullTimeEmployees": 60, "companyOfficers": [{"maxAge": 1, "name": "Mr. Adam K. Simpson", "age": 46, "title": "Pres, CEO, Co-Founder & Director", "yearBorn": 1976, "fiscalYear": 2022, "totalPay": {"raw": 855950, "fmt": "855.95k", "longFmt": "855,950"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 2381243, "fmt": "2.38M", "longFmt": "2,381,243"}}, {"maxAge": 1, "name": "Mr. Niranjan  Kanesa-thasan M.D.", "age": 61, "title": "Chief Medical Officer", "yearBorn": 1961, "fiscalYear": 2022, "totalPay": {"raw": 641550, "fmt": "641.55k", "longFmt": "641,550"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 397752, "fmt": "397.75k", "longFmt": "397,752"}}, {"maxAge": 1, "name": "Dr. Cassia  Cearley Ph.D.", "age": 39, "title": "Treasurer & Chief Bus. Officer", "yearBorn": 1983, "fiscalYear": 2022, "totalPay": {"raw": 632150, "fmt": "632.15k", "longFmt": "632,150"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 665210, "fmt": "665.21k", "longFmt": "665,210"}}, {"maxAge": 1, "name": "Mr. Neil  King Ph.D.", "title": "Chair of Scientific Advisory Board & Co-Founder", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Dr. David  Baker M.D., Ph.D.", "title": "Co-founder & Member of Scientific Advisory Board", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Thomas Joseph Russo C.F.A.", "age": 50, "title": "Chief Financial Officer", "yearBorn": 1972, "fiscalYear": 2021, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Ms. Jennifer  Raymond", "title": "Sr. VP of Technical Operations", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Douglas A. Holtzman M.P.H., Ph.D.", "age": 57, "title": "Chief Scientific Officer", "yearBorn": 1965, "fiscalYear": 2020, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Ms. Elizabeth  Bekiroglu", "age": 52, "title": "Gen. Counsel & Corp. Sec.", "yearBorn": 1970, "fiscalYear": 2021, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Ms. Lori  Stewart", "title": "Sr. VP of People & Culture", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}], "auditRisk": 8, "boardRisk": 6, "compensationRisk": 10, "shareHolderRightsRisk": 8, "overallRisk": 9, "governanceEpochDate": 1682899200, "compensationAsOfEpochDate": 1672444800, "maxAge": 86400}}], "error": null}}